The Board proposes the development of rule amendments set forth additional entities approved by the Board to provide the prescribing controlled substances course for licensure renewal and add additional entities to the recent new rule requiring the ...

 

DEPARTMENT OF HEALTH

Board of Osteopathic Medicine

RULE NOS.:RULE TITLES:

64B15-13.001Continuing Education for Biennial Renewal

64B15-13.0025Requirement for Continuing Education Course on Prescribing Controlled Substances

PURPOSE AND EFFECT: The Board proposes the development of rule amendments set forth additional entities approved by the Board to provide the prescribing controlled substances course for licensure renewal and add additional entities to the recent new rule requiring the course for prescribers prior to January 31, 2019.

SUBJECT AREA TO BE ADDRESSED: Additional entities approved to provide the prescribing controlled substances course for licensure renewal and additional entities to the rule requiring the course for prescribers prior to January 31, 2019.

RULEMAKING AUTHORITY: 456.013, 456.0301, 459.005, 459.008(4) FS.

LAW IMPLEMENTED: 456.013, 456.0301, 456.031, 459.008 FS.

IF REQUESTED IN WRITING AND NOT DEEMED UNNECESSARY BY THE AGENCY HEAD, A RULE DEVELOPMENT WORKSHOP WILL BE NOTICED IN THE NEXT AVAILABLE FLORIDA ADMINISTRATIVE REGISTER.

THE PERSON TO BE CONTACTED REGARDING THE PROPOSED RULE DEVELOPMENT AND A COPY OF THE PRELIMINARY DRAFT, IF AVAILABLE, IS: Kama Monroe, Executive Director, Board of Osteopathic Medicine/MQA, 4052 Bald Cypress Way, Bin #C06, Tallahassee, Florida 32399-3256.

THE PRELIMINARY TEXT OF THE PROPOSED RULE DEVELOPMENT IS AVAILABLE AT NO CHARGE FROM THE CONTACT PERSON LISTED ABOVE.